Compare FTEK & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTEK | NEPH |
|---|---|---|
| Founded | 1987 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.1M | 39.0M |
| IPO Year | 1997 | 2004 |
| Metric | FTEK | NEPH |
|---|---|---|
| Price | $1.40 | $3.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | ★ 143.8K | 38.4K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1000.00 |
| EPS | N/A | ★ 0.12 |
| Revenue | ★ $30,467,000.00 | $18,789,000.00 |
| Revenue This Year | $5.81 | $17.81 |
| Revenue Next Year | $18.08 | $15.90 |
| P/E Ratio | ★ N/A | $29.75 |
| Revenue Growth | N/A | ★ 32.67 |
| 52 Week Low | $1.17 | $2.66 |
| 52 Week High | $2.88 | $6.42 |
| Indicator | FTEK | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 32.61 | 44.10 |
| Support Level | $1.35 | $3.19 |
| Resistance Level | $1.53 | $3.78 |
| Average True Range (ATR) | 0.09 | 0.28 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 13.84 | 69.23 |
Fuel Tech Inc is a technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling for boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.